![Caroline Loew](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Caroline Loew
Nessuna posizione attualmente
Profilo
Caroline J.
Loew worked at Bristol Myers Squibb Co. as Vice President & Head-Research from 2015 to 2018.
From 2018 to 2022, Dr. Loew was President, Chief Executive Officer & Director at Glympse Bio, Inc. Dr. Loew served as Director at Mural Oncology Plc in 2023.
Dr. Loew completed undergraduate and doctorate degrees at Imperial College London.
Precedenti posizioni note di Caroline Loew
| Società | Posizione | Fine |
|---|---|---|
Glympse Bio, Inc.
 Glympse Bio, Inc. BiotechnologyHealth Technology Develops protein based diagnostic tests that detect and diagnose Alzheimer's disease | Amministratore Delegato | 01/08/2022 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/10/2018 |
Formazione di Caroline Loew
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
22
Relazioni di 1° grado
3
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Imperial College London
 Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Glympse Bio, Inc.
Glympse Bio, Inc. BiotechnologyHealth Technology Develops protein based diagnostic tests that detect and diagnose Alzheimer's disease | Health Technology |
